Cognitive Training for Alzheimer's Disease
(PACT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a specific type of computer-based brain training can delay memory problems or dementia. Participants will either engage in computerized cognitive training (also known as cognitive therapy or brain training) or participate in stimulating computer activities. The trial seeks individuals aged 65 or older who can read from a computer screen, understand conversational speech, and currently have no memory issues. The goal is to help maintain mental sharpness and quality of life for older adults. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants a chance to contribute to a potentially groundbreaking treatment.
Will I have to stop taking my current medications?
The trial excludes participants who are using medications typically prescribed for dementia, such as Namenda, Memantine, and Donepezil. If you are taking these medications, you would not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that computerized cognitive training (CCT) is safe and can improve brain functions in older adults. Studies have found that CCT enhances memory skills, such as remembering words and pictures. It is particularly beneficial for individuals with mild cognitive impairment (MCI), a condition that can lead to Alzheimer's disease.
Previous research indicates that CCT is well-tolerated, with most people not experiencing negative side effects. Meta-analyses confirm that CCT is safe for older adults.
Research also supports the effectiveness and safety of computerized cognitive stimulation. Both training and stimulation methods improve thinking skills in those at risk of cognitive decline.
In summary, both computerized cognitive training and stimulation are considered safe for humans. They have been tested and shown to support brain health without causing harm.12345Why are researchers excited about this trial's treatments?
Researchers are excited about the cognitive training and computerized cognitive stimulation methods for Alzheimer's disease because they offer a non-drug approach to managing the condition. Unlike traditional treatments such as cholinesterase inhibitors or memantine, which primarily target chemical imbalances in the brain, these techniques focus on enhancing cognitive abilities through mental exercises. They leverage technology to engage specific brain functions, potentially slowing cognitive decline more naturally and with fewer side effects. This innovative approach could complement existing therapies and offer patients more holistic care options.
What evidence suggests that this trial's treatments could be effective for Alzheimer's disease?
Research has shown that computerized cognitive training (CCT), which participants in this trial may receive, can improve various types of memory, such as remembering words and pictures. One study found that this training enhances skills like planning, focusing, and short-term memory. Another study suggested that CCT might even reverse up to ten years of brain aging, making learning and remembering easier. Meanwhile, computerized cognitive stimulation, another treatment option in this trial, proves helpful, especially for individuals in the early stages of Alzheimer's disease. It has improved thinking skills in older adults, aiding in managing memory problems related to dementia.23678
Are You a Good Fit for This Trial?
This trial is for individuals aged 65 or older with no signs of Mild Cognitive Impairment (MCI) or dementia, as indicated by a Montreal Cognitive Assessment score >=26. Participants must be able to perform computer exercises and have good mental health without severe depression. They should not be on dementia medications nor have completed similar cognitive training recently.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete computerized cognitive training with 25 initial sessions over 3 to 5 months, followed by booster sessions at 1 and 2 years
Booster Sessions
Participants complete 10 additional sessions of training at 1-year and 2-years
Follow-up
Participants are monitored for incidence of mild cognitive impairment or dementia
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Training
- Computerized Cognitive Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Florida
Lead Sponsor
National Institute on Aging (NIA)
Collaborator